CLII

5th December 2025

Princess Chichibu Memorial TB Global Award at 2025 World Conference on Lung Health

Prof Keertan Dheda was awarded the Princess Chichibu Memorial TB Global Award, presented by the Japan Anti-Tuberculosis Association (JATA), in recognition of his exceptional scientific contributions and his global leadership in the fight against tuberculosis (TB).
11th February 2025

Tuberculosis Drug Resistance: The Alarming Surge of Bedaquiline Resistance in South Africa

Prof Keertan Dheda, Professor of Respiratory Medicine at the University of Cape Town and Professor of Mycobacteriology and Global Health at LSHTM, is a world leader in the field of TB diagnosis and transmission. In this interview with Dr Richard Wall, he discusses the impending threat of bedaquiline-resistant TB in South Africa and the steps required to minimise its spread.
5th November 2024

Best Publication Clinical Sciences

Assoc Prof Ali Esmail, Head of the CLII Clinical Trials Unit, won Best Publication Clinical Sciences (Early Career) 2024. Click on the link to read all […]
18th December 2023

A Big Misconception About the World’s Greatest Infectious Killer

Growing up in India, which for decades has clocked millions of tuberculosis cases each year, Lalita Ramakrishnan was intimately familiar with how devastating the disease can be. The world’s greatest infectious killer, rivaled only by SARS-CoV-2, Mycobacterium tuberculosis spreads through the air and infiltrates the airways, in many cases destroying the lungs.
17th November 2023

Tuberculosis Surpasses COVID-19 as Most Deadly Infectious Disease

“Almost a third of newly ill patients with TB globally remain undetected or undiagnosed,” Dr. Keertan Dheda, professor of TB research at the London School of Hygiene and Tropical Medicine, wrote to The Epoch Times. This can be due to poor diagnostic techniques and difficulty accessing care.